Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy of Cmvpepvax for Preventing CMV Reactivation/Disease after Matched Related/Unrelated Donor Hematopoietic Cell Transplant

Blood (2021) 138 (Supplement 1): 2887.

https://doi.org/10.1182/blood-2021-153312

Published: 2021

Journal Articles

Vaccination of Hematopoietic Stem Cell (HCT) Donors with Triplex, a Novel Cytomegalovirus Vaccine: Safety, Feasibility and Adoptive Transfer of Protective CMV-Specific T Cells in HCT Recipients

Ryotaro Nakamura, MD, Corinna La Rosa, PhD, Ibrahim Aldoss, MD, Qiao Zhou, B.S., Chetan Raj Lingaraju, M.S., Joy Martinez, M.S., Teodora Kaltcheva, PhD, Don J. Diamond, PhD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-141811

Published: 2020

Journal Articles

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

Corinna La Rosa, Jeff Longmate, Joy Martinez, Qiao Zhou, Teodora I. Kaltcheva, Weimin Tsai, Jennifer Drake, Mary Carroll, Felix Wussow, Flavia Chiuppesi, Nicola Hardwick, Sanjeet Dadwal, Ibrahim Aldoss, Ryotaro Nakamura, John A. Zaia, Don J. Diamond

Blood (2017) 129 (1): 114–125.

https://doi.org/10.1182/blood-2016-07-729756

Published: 2017

Includes: Supplemental data

Journal Articles

Safety, Maximum Tolerated Dose and Immunogenicity of CMV-MVA-Triplex in Healthy Volunteers with or without Prior Immunity to CMV and Vaccinia

Don J. Diamond, PhD, Corinna La Rosa, PhD, Jeffrey Longmate, PhD, Joy Martinez, Qiao Zhou, Theodora Kaltcheva, PhD, Jennifer Drake, Mary Carroll, Sanjeet Dadwal, MD, Ibrahim Aldoss, MD, Ryotaro Nakamura, MD, John A. Zaia, MD

Blood (2015) 126 (23): 3108.

https://doi.org/10.1182/blood.V126.23.3108.3108

Published: 2015

Journal Articles

Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients

Ryotaro Nakamura, MD, Corinna La Rosa, PhD, Jeff Longmate, PhD, Margaret O'Donnell, MD FRCPC, Ji-Lian Cai, MD, Len Farol, MD, Amandeep Salhotra, MD, David S Snyder, MD, Jennifer Drake, Cynthia Slape, James Merson, PhD, John A Zaia, MD, Stephen J. Forman, Don J. Diamond, PhD

Blood (2014) 124 (21): 183.

https://doi.org/10.1182/blood.V124.21.183.183

Published: 2014

Journal Articles

Detection and Characterization of Antigen-Driven CD8 + T Lymphocytes Specific for Wilms' Tumor Antigen in Patients with Non-Hodgkin Lymphoma

Ryotaro Nakamura, MD, Anna Israyelyan, MD, PhD, Corinna La Rosa, PhD, Weimin Tsai, BS, Teodora Kaltcheva, PhD, Tumul Srivastava, PhD, Jessica Lo, BS, Lia Aquino, Jianqiang Li, PhD, Young Kim, MD, Joycelynne Palmer, PhD, David Senitzer, PhD, John Zaia, MD, Stephen J. Forman, MD, Don J. Diamond, PhD

Blood (2011) 118 (21): 953.

https://doi.org/10.1182/blood.V118.21.953.953

Published: 2011

Journal Articles

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice

Simon F. Lacey, Corinna La Rosa, Teodora Kaltcheva, Tumul Srivastava, Aprille Seidel, Wendi Zhou, Ravindra Rawal, Katharine Hagen, Aparna Krishnan, Jeff Longmate, Helen A. Andersson, Lisa St. John, Ravi Bhatia, Vinod Pullarkat, Stephen J. Forman, Laurence J. N. Cooper, Jeffrey Molldrem, Don J. Diamond

Blood (2011) 118 (8): 2159–2169.

https://doi.org/10.1182/blood-2011-04-349951

Published: 2011

Journal Articles

Pre-Clinical Development of a Subunit Vaccine Expressing an IE1-IE2 Fusion Protein of HCMV.

Zhongde Wang, PHD, Wendy Zhou, PHD, MD, Tumul Srivastava, PHD, Corinna La Rosa, PHD, Stephen J. Forman, MD, John A. Zaia, MD, Don J. Diamond, PhD

Blood (2007) 110 (11): 165.

https://doi.org/10.1182/blood.V110.11.165.165

Published: 2007

Journal Articles

Functional Comparison and Longitudinal Assessment of Tri-Functional T-Cells Recognizing CMV pp65 and IE-1 Polypeptides in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

Don J. Diamond, PhD, Simon F. Lacey, PhD, Corinna La Rosa, PhD, Wendy Zhou, PHD,MD, Ghislaine Gallez-Hawkins, MS, Lia Thao, MS, Jeff Longmate, PhD, Ajit Limaye, MD, Ricardo Spielberger, MD, Stephen J. Forman, MD, John A. Zaia, MD

Blood (2006) 108 (11): 2936.

https://doi.org/10.1182/blood.V108.11.2936.2936

Published: 2006

Journal Articles

Vaccine Properties of a Novel Marker Gene-Free Recombinant Modified Vaccinia Ankara (MVA) Expressing Immunodominant CMV Antigens.

Don J. Diamond, PhD, Zhongde Wang, PhD, Corinna La Rosa, PhD, Tumul Srivastava, PHD, Wendy Zhou, MD, PHD, Zhongqi Li, PhD, Heang Ly, Tamineh Akbarnejad, MS, Aparna Krishnan, MS, William J. Britt, MD

Blood (2006) 108 (11): 2858.

https://doi.org/10.1182/blood.V108.11.2858.2858

Published: 2006

Journal Articles

Development and Immunologic Characterization of Multi-Antigen Expressing Attenuated Poxviruses for Immunotherapy of CMV Infection in HSCT Recipients.

Don J. Diamond, PhD, Zhongde Wang, PhD, Corinna La Rosa, PhD, Goetz U. Grigoleit, MD, Angelo Mandarino, PhD, Simon F. Lacey, PhD, Holger Ludwig, PhD, William J. Britt, MD, Gerd Sutter, PhD, Hermann Einsele, MD

Blood (2005) 106 (11): 480.

https://doi.org/10.1182/blood.V106.11.480.480

Published: 2005

Journal Articles

Rapid Ex Vivo Expansion of CMV Specific CTL Suitable for Clinical Immunotherapy Using CpG-DNA Matured PBMC Infected with Recombinant MVA.

Don J. Diamond, PhD, Zhongde Wang, PhD, Simon F. Lacey, PhD, Corinna La Rosa, PhD

Blood (2004) 104 (11): 5102.

https://doi.org/10.1182/blood.V104.11.5102.5102

Published: 2004

Journal Articles

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells

Zhongde Wang, Corinna La Rosa, Shahram Mekhoubad, Simon F. Lacey, Maria C. Villacres, Susan Markel, Jeff Longmate, Joshua D. I. Ellenhorn, Robert F. Siliciano, Christopher Buck, William J. Britt, Don J. Diamond

Blood (2004) 104 (3): 847–856.

https://doi.org/10.1182/blood-2003-10-3469

Published: 2004

Journal Articles

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice

Corinna La Rosa, Zhongde Wang, John C. Brewer, Simon F. Lacey, Maria C. Villacres, Rahul Sharan, Radhika Krishnan, Matthew Crooks, Susan Markel, Rebecca Maas, Don J. Diamond

Blood (2002) 100 (10): 3681–3689.

https://doi.org/10.1182/blood-2002-03-0926

Published: 2002

Journal Articles

Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries

Corinna La Rosa, Radhika Krishnan, Susan Markel, Jonathan P. Schneck, Richard Houghten, Clemencia Pinilla, Don J. Diamond

Blood (2001) 97 (6): 1776–1786.

https://doi.org/10.1182/blood.V97.6.1776

Published: 2001

NARROW

A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy of Cmvpepvax for Preventing CMV Reactivation/Disease after Matched Related/Unrelated Donor Hematopoietic Cell Transplant

Vaccination of Hematopoietic Stem Cell (HCT) Donors with Triplex, a Novel Cytomegalovirus Vaccine: Safety, Feasibility and Adoptive Transfer of Protective CMV-Specific T Cells in HCT Recipients

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

Safety, Maximum Tolerated Dose and Immunogenicity of CMV-MVA-Triplex in Healthy Volunteers with or without Prior Immunity to CMV and Vaccinia

Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients

Detection and Characterization of Antigen-Driven CD8 + T Lymphocytes Specific for Wilms' Tumor Antigen in Patients with Non-Hodgkin Lymphoma

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice

Pre-Clinical Development of a Subunit Vaccine Expressing an IE1-IE2 Fusion Protein of HCMV.

Functional Comparison and Longitudinal Assessment of Tri-Functional T-Cells Recognizing CMV pp65 and IE-1 Polypeptides in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

Vaccine Properties of a Novel Marker Gene-Free Recombinant Modified Vaccinia Ankara (MVA) Expressing Immunodominant CMV Antigens.

Development and Immunologic Characterization of Multi-Antigen Expressing Attenuated Poxviruses for Immunotherapy of CMV Infection in HSCT Recipients.

Rapid Ex Vivo Expansion of CMV Specific CTL Suitable for Clinical Immunotherapy Using CpG-DNA Matured PBMC Infected with Recombinant MVA.

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice

Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only